Next report date
Report period
H1 2024
EPS estimate
—
Revenue estimate
—
0.43HKD
352.87 MHKD
1.20 BHKD
208.02 M
About ORBUSNEICH MEDICAL GRP HLDGS LTD
Sector
Industry
CEO
David Chien
Headquarters
Hong Kong
Employees (FY)
1.25 K
ISIN
KYG6773B1005
FIGI
BBG01BYJG034
OrbusNeich Medical Group Holdings Ltd. operates as an investment holding company. The firm through its subsidiaries engages in the manufacturing, trading, sales and marketing of medical devices & instruments used for the treatment of coronary and peripheral vascular diseases. The company was founded on July 22, 2021 and is headquartered in Hong Kong.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 6929 is 3.83 HKD — it has increased by 4.08% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange ORBUSNEICH MEDICAL GRP HLDGS LTD stocks are traded under the ticker 6929.
ORBUSNEICH MEDICAL GRP HLDGS LTD is going to release the next earnings report on Aug 16, 2024. Keep track of upcoming events with our Earnings Calendar.
6929 stock is 5.41% volatile and has beta coefficient of 0.57. Check out the list of the most volatile stocks — is ORBUSNEICH MEDICAL GRP HLDGS LTD there?
ORBUSNEICH MEDICAL GRP HLDGS LTD revenue for the last quarter amounts to 638.16 M HKD despite the estimated figure of 666.30 M HKD. In the next quarter revenue is expected to reach 515.50 M HKD.
Yes, you can track ORBUSNEICH MEDICAL GRP HLDGS LTD financials in yearly and quarterly reports right on TradingView.
6929 stock has risen by 4.93% compared to the previous week, the month change is a 26.40% rise, over the last year ORBUSNEICH MEDICAL GRP HLDGS LTD has showed a 69.84% decrease.
6929 net income for the last quarter is 155.53 M HKD, while the quarter before that showed 197.40 M HKD of net income which accounts for −21.21% change. Track more ORBUSNEICH MEDICAL GRP HLDGS LTD financial stats to get the full picture.
Like other stocks, 6929 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ORBUSNEICH MEDICAL GRP HLDGS LTD stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 27, 2024, the company has 1.25 K employees. See our rating of the largest employees — is ORBUSNEICH MEDICAL GRP HLDGS LTD on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ORBUSNEICH MEDICAL GRP HLDGS LTD technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ORBUSNEICH MEDICAL GRP HLDGS LTD stock shows the buy signal. See more of ORBUSNEICH MEDICAL GRP HLDGS LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ORBUSNEICH MEDICAL GRP HLDGS LTD future price: according to them, 6929 price has a max estimate of 8.00 HKD and a min estimate of 5.81 HKD. Read a more detailed ORBUSNEICH MEDICAL GRP HLDGS LTD forecast: see what analysts think of ORBUSNEICH MEDICAL GRP HLDGS LTD and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ORBUSNEICH MEDICAL GRP HLDGS LTD EBITDA is 324.51 M HKD, and current EBITDA margin is 26.93%. See more stats in ORBUSNEICH MEDICAL GRP HLDGS LTD financial statements.